Amicus Therapeutics to Present at Cowen and Company 34th Annual Health Care Conference

[at noodls] – CRANBURY, N.J., Feb. 27, 2014 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that … more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view